Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia

被引:4
|
作者
Tobin, Ruarai J. J. [1 ]
Wood, James G. G. [2 ]
Jayasundara, Duleepa [3 ]
Sara, Grant [3 ,4 ]
Walker, Camelia R. R. [5 ]
Martin, Genevieve E. E. [6 ,7 ,8 ]
McCaw, James M. M. [1 ,5 ,8 ]
Shearer, Freya M. M. [1 ]
Price, David J. J. [1 ,8 ]
机构
[1] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Australia
[2] Univ New South Wales, Sch Populat Hlth, Sydney, Australia
[3] New South Wales Minist Hlth, Syst Informat & Analyt Branch, Sydney, Australia
[4] Univ Sydney, Fac Med & Hlth, Northern Clin Sch, Sydney, Australia
[5] Univ Melbourne, Sch Math & Stat, Melbourne, Australia
[6] Univ Melbourne, Melbourne Med Sch, Dept Infect Dis, Melbourne, Australia
[7] Monash Univ, Cent Clin Sch, Dept Infect Dis, Melbourne, Australia
[8] Univ Melbourne, Royal Melbourne Hosp, Doherty Inst Infect & Immun, Melbourne, Australia
基金
英国医学研究理事会;
关键词
COVID-19; Survival analysis; Multi-state model; Length of stay;
D O I
10.1186/s12879-022-07971-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe distribution of the duration that clinical cases of COVID-19 occupy hospital beds (the 'length of stay') is a key factor in determining how incident caseloads translate into health system burden. Robust estimation of length of stay in real-time requires the use of survival methods that can account for right-censoring induced by yet unobserved events in patient progression (e.g. discharge, death). In this study, we estimate in real-time the length of stay distributions of hospitalised COVID-19 cases in New South Wales, Australia, comparing estimates between a period where Delta was the dominant variant and a subsequent period where Omicron was dominant.MethodsUsing data on the hospital stays of 19,574 individuals who tested positive to COVID-19 prior to admission, we performed a competing-risk survival analysis of COVID-19 clinical progression.ResultsDuring the mixed Omicron-Delta epidemic, we found that the mean length of stay for individuals who were discharged directly from ward without an ICU stay was, for age groups 0-39, 40-69 and 70 +, respectively, 2.16 (95% CI: 2.12-2.21), 3.93 (95% CI: 3.78-4.07) and 7.61 days (95% CI: 7.31-8.01), compared to 3.60 (95% CI: 3.48-3.81), 5.78 (95% CI: 5.59-5.99) and 12.31 days (95% CI: 11.75-12.95) across the preceding Delta epidemic (1 July 2021-15 December 2021). We also considered data on the stays of individuals within the Hunter New England Local Health District, where it was reported that Omicron was the only circulating variant, and found mean ward-to-discharge length of stays of 2.05 (95% CI: 1.80-2.30), 2.92 (95% CI: 2.50-3.67) and 6.02 days (95% CI: 4.91-7.01) for the same age groups.ConclusionsHospital length of stay was substantially reduced across all clinical pathways during a mixed Omicron-Delta epidemic compared to a prior Delta epidemic, contributing to a lessened health system burden despite a greatly increased infection burden. Our results demonstrate the utility of survival analysis in producing real-time estimates of hospital length of stay for assisting in situational assessment and planning of the COVID-19 response.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia
    Ruarai J. Tobin
    James G. Wood
    Duleepa Jayasundara
    Grant Sara
    Camelia R. Walker
    Genevieve E. Martin
    James M. McCaw
    Freya M. Shearer
    David J. Price
    BMC Infectious Diseases, 23
  • [2] Development of a model by LASSO to predict hospital length of stay (LOS) in patients with the SARS-Cov-2 omicron variant
    Zhang, Jianxiang
    Li, Lei
    Hu, Xiaobo
    Cui, Guangying
    Sun, Ranran
    Zhang, Donghua
    Li, Juan
    Li, Yonghong
    Shen, Shen
    He, Ping
    Yu, Zujiang
    Ren, Zhigang
    VIRULENCE, 2023, 14 (01)
  • [3] Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data
    De Salazar, Pablo M.
    Lu, Fred
    Hay, James A.
    Gomez-Barroso, Diana
    Fernandez-Navarro, Pablo
    Martinez, Elena, V
    Astray-Mochales, Jenaro
    Amillategui, Rocio
    Garcia-Fulgueiras, Ana
    Chirlaque, Maria D.
    Sanchez-Migallon, Alonso
    Larrauri, Amparo
    Sierra, Maria J.
    Lipsitch, Marc
    Simon, Fernando
    Santillana, Mauricio
    Hernan, Miguel A.
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (03)
  • [4] Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK
    Postans, Mark
    Pacchiarini, Nicole
    Song, Jiao
    Cottrell, Simon
    Williams, Catie
    Beazer, Andrew
    Moore, Catherine
    Connor, Thomas R.
    Williams, Christopher
    PLOS ONE, 2024, 19 (09):
  • [5] Whole-genome single molecule real-time sequencing of SARS-CoV-2 Omicron
    Nicot, Florence
    Tremeaux, Pauline
    Latour, Justine
    Carcenac, Romain
    Demmou, Sofia
    Jeanne, Nicolas
    Ranger, Noemie
    De Smet, Clementine
    Raymond, Stephanie
    Dimeglio, Chloe
    Izopet, Jacques
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [6] Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas
    Arantes, Ighor
    Bello, Gonzalo
    Nascimento, Valdinete
    Souza, Victor
    da Silva, Arlesson
    Silva, Dejanane
    Nascimento, Fernanda
    Mejia, Matilde
    Brandao, Maria Julia
    Goncalves, Luciana
    Silva, George
    da Costa, Cristiano Fernandes
    Abdalla, Ligia
    Santos, Joao Hugo
    Ramos, Tatyana Costa Amorim
    Piantham, Chayada
    Ito, Kimihito
    Siqueira, Marilda Mendonca
    Resende, Paola Cristina
    Wallau, Gabriel Luz
    Delatorre, Edson
    Graf, Tiago
    Naveca, Felipe Gomes
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [7] Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas
    Ighor Arantes
    Gonzalo Bello
    Valdinete Nascimento
    Victor Souza
    Arlesson da Silva
    Dejanane Silva
    Fernanda Nascimento
    Matilde Mejía
    Maria Júlia Brandão
    Luciana Gonçalves
    George Silva
    Cristiano Fernandes da Costa
    Ligia Abdalla
    João Hugo Santos
    Tatyana Costa Amorim Ramos
    Chayada Piantham
    Kimihito Ito
    Marilda Mendonça Siqueira
    Paola Cristina Resende
    Gabriel Luz Wallau
    Edson Delatorre
    Tiago Gräf
    Felipe Gomes Naveca
    Nature Communications, 14
  • [8] Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
    Dong, Rui
    Hu, Taojun
    Zhang, Yunjun
    Li, Yang
    Zhou, Xiao-Hua
    VACCINES, 2022, 10 (04)
  • [9] The effect of nirmatrelvir-ritonavir on viral clearance and length of hospital stay in patients infected with SARS-CoV-2 omicron variants
    Wang, Yu
    Zhao, Danyang
    Chen, Xubo
    Liu, Xinbing
    Xiao, Wenying
    Feng, Liuliu
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (02)
  • [10] A new SYBR Green real-time PCR to detect SARS-CoV-2
    D. R. Marinowic
    G. Zanirati
    F. V. F. Rodrigues
    M. V. C. Grahl
    A. M. Alcará
    D. C. Machado
    J. C. Da Costa
    Scientific Reports, 11